An open label Positron Emission Tomography (PET) study to determine central mGluR5 receptor occupancy of AZD2516

Study identifier:D2080C00009

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An open label Positron Emission Tomography (PET) study with [11C]AZ12713580 to determine central mGluR5 receptor occupancy of AZD2516 after oral administration to healthy subjects

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD2516

Sex

All

Actual Enrollment

6

Study type

Interventional

Age

20 Years - 45 Years

Date

Study Start Date: 01 Apr 2009
Primary Completion Date: -
Study Completion Date: 01 Oct 2009

Study design

Allocation: N/A
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria